Global "Birkenstock Fever" ignites Birkenstock's growth engine. Wall Street calls for a 50% surge to start.

Wall Street analysts have recently become increasingly bullish on Birkenstock Holding (BIRK.US), the creator of the footbed sandal category, mainly due to the company's strong performance data and the fact that the negative impact of Trump's tariff policy on the company's fundamentals is better than Wall Street had previously expected. Some analysts even exclaim that the company's investment prospects surpass those of sports brands like Nike, Inc. Class B and Adidas, making it one of the best shoe stocks globally. Stock market analyst Jay Sole from the financial giant UBS Group AG recently raised the company's target price from $76 to $77 and maintained a "buy" rating, citing strong growth expectations for Birkenstock sandals and emphasizing that the impact of Trump's tariff pressures is short-lived and more optimistic than market expectations. UBS Group AG analyst's bullish view came before Birkenstock, the "pioneer of Birkenstock sandals," released its incredibly strong performance report for the third quarter of fiscal year 2025 (FQ3). As of Tuesday's closing of the US stock market, Birkenstock's stock closed at $50.13, indicating a potential upside of 50% over the next 12 months as seen by UBS Group AG analysts, potentially entering a new super bull market and completely shaking off the sluggish trend of Birkenstock's stock price falling more than 10% this year. The latest financial data shows that Birkenstock Holding saw a 16% increase in revenue in FQ3 based on fixed exchange rates, with a reported revenue growth rate of about 12%, both exceeding the average expectations of Wall Street analysts. This double-digit growth occurred in all of the company's business segments and channels, with the Americas and the EMEA and APAC markets achieving year-on-year growth of 16%, 13%, and 24% respectively based on fixed exchange rates. The company's B2B sales channel was a key driver, with an 18% increase in B2B revenue based on fixed exchange rates, outperforming the D2C channel. The company's total revenue for the quarter reached $739.62 million, surpassing the average expectations of Wall Street analysts. Birkenstock successfully implemented price increases for its core products in the third quarter, with no significant negative market reaction. The company is also expanding its retail business targeting end consumers, adding 13 stores globally, with a core growth target of reaching approximately 100 stores by the end of fiscal year 2025. Birkenstock Holding is the creator of the popular Birkenstock sandals, primarily engaged in the production, manufacturing, and sales of Birkenstock footwear products. Its product range also includes skincare products and stylish accessories. Birkenstock sandals are typically defined as trendy sandals with an anatomically shaped cork-latex footbed. Birkenstock is both the pioneer of this category and the inventor of the core footbed technology. The core of Birkenstock sandals lies in the cork-latex footbed, which provides functions such as shock absorption, arch support, pressure distribution, and a good foot microclimate. This wearing experience and the concept of "healthy walking" give Birkenstock a significant advantage in long-standing/commuting scenarios. The term "Birken fever" refers to the global popularity of this category of sandals based on the concept of "healthy walking," benefiting from both the real comfort/health functions and the collective driving force of sustainable storytelling, cultural diffusion, and high-end fashion rebranding.